What is Us Pharmatech?
Us Pharmatech operates as a premier manufacturer of dietary supplements, distinguishing itself through comprehensive OEM and private label services. The company provides an end-to-end solution that encompasses product formulation, packaging, labeling, and logistics. With a vast intellectual property portfolio featuring over 10,000 active formulas and a research and development department that has successfully engineered more than 40,000 unique solutions, the firm maintains a dominant presence in both solid and liquid supplement production. By catering to businesses seeking high-quality manufacturing standards, Us Pharmatech has established itself as a critical partner in the nutraceutical supply chain, ensuring scalability and precision for its diverse client base.
How much funding has Us Pharmatech raised?
Us Pharmatech has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Us Pharmatech
PPP
Public-Private Partnership
What's next for Us Pharmatech?
Following this major strategic investment, Us Pharmatech is well-positioned to accelerate its industrial scaling efforts. The focus will likely shift toward enhancing automated production lines and expanding R&D capacity to address emerging trends in personalized nutrition and wellness. By utilizing this capital to refine its supply chain efficiency and broaden its manufacturing footprint, the company aims to solidify its leadership in the private label market. As the nutraceutical industry continues to evolve, Us Pharmatech's commitment to formula innovation and high-volume output will be instrumental in maintaining its competitive edge and driving long-term value for its stakeholders.
See full Us Pharmatech company page
